Similar articles for PMID: 9476143

Year	Number of Results
1965	1
1972	1
1991	1
1996	1
1997	1
1998	1
2001	4
2002	2
2003	1
2004	1
2005	5
2006	2
2007	6
2008	1
2009	1
2011	1
2012	1
2024	0

1

Transporters and the blood-brain barrier (BBB).

De Boer AB, De Lange EL, Van der Sandt IC, Breimer DD. De Boer AB, et al. Int J Clin Pharmacol Ther. 1998 Jan;36(1):14-5. Int J Clin Pharmacol Ther. 1998. PMID: 9476143 No abstract available.

2

P-glycoprotein efflux at the blood-brain barrier mediates differences in brain disposition and pharmacodynamics between two structurally related neurokinin-1 receptor antagonists.

Smith BJ, Doran AC, McLean S, Tingley FD 3rd, O'Neill BT, Kajiji SM. Smith BJ, et al. J Pharmacol Exp Ther. 2001 Sep;298(3):1252-9. J Pharmacol Exp Ther. 2001. PMID: 11504828

3

Functional characterization and comparison of the outer blood-retina barrier and the blood-brain barrier.

Steuer H, Jaworski A, Elger B, Kaussmann M, Keldenich J, Schneider H, Stoll D, Schlosshauer B. Steuer H, et al. Invest Ophthalmol Vis Sci. 2005 Mar;46(3):1047-53. doi: 10.1167/iovs.04-0925. Invest Ophthalmol Vis Sci. 2005. PMID: 15728564

4

Modulation of P-glycoprotein transport activity in the mouse blood-brain barrier by rifampin.

Zong J, Pollack GM. Zong J, et al. J Pharmacol Exp Ther. 2003 Aug;306(2):556-62. doi: 10.1124/jpet.103.049452. Epub 2003 Apr 29. J Pharmacol Exp Ther. 2003. PMID: 12721332

5

GAT2/BGT-1 as a system responsible for the transport of gamma-aminobutyric acid at the mouse blood-brain barrier.

Takanaga H, Ohtsuki S, Hosoya Ki, Terasaki T. Takanaga H, et al. J Cereb Blood Flow Metab. 2001 Oct;21(10):1232-9. doi: 10.1097/00004647-200110000-00012. J Cereb Blood Flow Metab. 2001. PMID: 11598501

6

Brain pericytes contribute to the induction and up-regulation of blood-brain barrier functions through transforming growth factor-beta production.

Dohgu S, Takata F, Yamauchi A, Nakagawa S, Egawa T, Naito M, Tsuruo T, Sawada Y, Niwa M, Kataoka Y. Dohgu S, et al. Brain Res. 2005 Mar 21;1038(2):208-15. doi: 10.1016/j.brainres.2005.01.027. Brain Res. 2005. PMID: 15757636

7

Inhibition of multidrug resistance transporter-1 facilitates neuroprotective therapies after focal cerebral ischemia.

Spudich A, Kilic E, Xing H, Kilic U, Rentsch KM, Wunderli-Allenspach H, Bassetti CL, Hermann DM. Spudich A, et al. Nat Neurosci. 2006 Apr;9(4):487-8. doi: 10.1038/nn1676. Epub 2006 Mar 26. Nat Neurosci. 2006. PMID: 16565717

8

Inhibition of P-glycoprotein activity at the primate blood-brain barrier increases the distribution of nelfinavir into the brain but not into the cerebrospinal fluid.

Kaddoumi A, Choi SU, Kinman L, Whittington D, Tsai CC, Ho RJ, Anderson BD, Unadkat JD. Kaddoumi A, et al. Drug Metab Dispos. 2007 Sep;35(9):1459-62. doi: 10.1124/dmd.107.016220. Epub 2007 Jun 25. Drug Metab Dispos. 2007. PMID: 17591677

9

Drug transporters in the epileptic brain.

Löscher W. Löscher W. Epilepsia. 2007;48 Suppl 1:8-13. doi: 10.1111/j.1528-1167.2007.00993.x. Epilepsia. 2007. PMID: 17316407 Free article. Review.

10

Functional expression and localization of P-glycoprotein at the blood brain barrier.

Bendayan R, Lee G, Bendayan M. Bendayan R, et al. Microsc Res Tech. 2002 Jun 1;57(5):365-80. doi: 10.1002/jemt.10090. Microsc Res Tech. 2002. PMID: 12112443 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

29 results

Results by year